Tuesday July 17, 2018
Home India Pakistan asks...

Pakistan asks India for more evidence regarding 26/11 Mumbai terror attacks

Lakhvi, who is living at an undisclosed location in Pakistan, was released from jail on bail last year, in 2015

3
//
384
Mumbai Terror Attack. Image source: scarletpensieve.blogspot.com
Republish
Reprint
  • Pakistan had arrested seven Lashkar-e-Toiba linked terrorists
  • Lakhvi, who is living in Pakistan, was released from jail on bail last year
  • India has been urging Pakistan to complete the trial at the earliest, but Pakistan asks for more evidence

ISLAMABAD: Pakistan on Thursday, June 30, demanded more evidence from India on the 26/11Mumbai terror attacks in order to bring the case to its “logical end”, the Foreign Office spokesperson said here.

“Foreign Secretary Aizaz Chaudhry has written a letter to concerned authorities across the border and has demanded further details regarding the evidence linking Pakistan to the attacks,” spokesperson Nafees Zakaria said, adding that “Islamabad would bring the Mumbai attacks case to its logical end.”

Zakaria said the response from the Indian side is still awaited. But the spokesperson did not elaborate when exactly the letter was written.

Pakistan had arrested seven Lashkar-e-Toiba linked terrorists, including presumed mastermind of the 26/11 attacks Zakiur Rehman Lakhvi, for their role in the 2008 attacks in which 166 people were killed and over 350 injured.

Follow NewsGram on Twitter: @NewsGram1

Lakhvi, who is living at an undisclosed location in Pakistan, was released from jail on bail last year. The other six suspects are lodged in a Rawalpindi jail.

India has been urging Pakistan to complete the trial at the earliest. It has said that enough evidence has been shared with Islamabad to prosecute the accused.

Zakiur Rehman Lakhvi. Image source: www.ndtv.com
Zakiur Rehman Lakhvi. Image source: www.ndtv.com

However, Pakistani officials say India has not provided enough evidence needed to successfully complete the trial.

Responding to Indian Prime Ministers Narendra Modi’s interview to the TimesNow news channel, Zakariya said the civil and military leadership of Pakistan were on the same page.

“The Pakistani nation feels proud of its armed forces.”

Follow NewsGram on facebook: NewsGram

Modi in his interview to the TV news channel earlier this week asserted that there were different types of forces operating in Pakistan and it was difficult to ascertain whom to engage in dialogue.

Meanwhile, the Foreign Office spokesperson said that the only way to resolve tensions between India and Pakistan was through dialogue. He stated that Islamabad was ready to hold dialogue with New Delhi.

“It has been said many times earlier that peace talks is the only way forward for relations between Pakistan and India,” he said. (IANS)

ALSO READ:

Click here for reuse options!
Copyright 2016 NewsGram

  • Aparna Gupta

    This is terrible. We have already sent them enough proofs and now the want more as to bring it to so called ‘logical end’.

  • AJ Krish

    Despite providing so much evidence, Pakistan has made their stand clear. They won’t fight terrorism, they will protect it!

  • Vrushali Mahajan

    Even the smallest of evidence should be enough to punish such people. Pakistan shouldn’t ask for what is not required.

SHARE
  • Aparna Gupta

    This is terrible. We have already sent them enough proofs and now the want more as to bring it to so called ‘logical end’.

  • AJ Krish

    Despite providing so much evidence, Pakistan has made their stand clear. They won’t fight terrorism, they will protect it!

  • Vrushali Mahajan

    Even the smallest of evidence should be enough to punish such people. Pakistan shouldn’t ask for what is not required.

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)